Pioglitazone after stroke or TIA reduces stroke and MI, but has significant harms as well

Pioglitazone after stroke or TIA reduces stroke and MI, but has significant harms as well is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central